Gastric Perforation

Gastric perforation is a severe, life-threatening surgical emergency characterized by a full-thickness defect in the stomach wall, leading to leakage of gastric contents (ingesta, hydrochloric acid, pepsin, and bacteria) into the peritoneal cavity. This results in chemical and bacterial peritonitis, which can rapidly progress to septic shock, systemic inflammatory response syndrome (SIRS), multi-organ dysfunction syndrome (MODS), and death if not promptly recognized and surgically managed. The condition may arise from various etiologies, including penetrating trauma, gastric ulceration, gastric dilatation-volvulus (GDV)-associated necrosis, foreign body perforation, iatrogenic injury, or neoplasia. Surgical intervention is mandatory, involving exploratory laparotomy, debridement of necrotic tissue, primary closure or resection and anastomosis, and copious peritoneal lavage. Perioperative management is critical, focusing on hemodynamic stabilization, antimicrobial therapy, and nutritional support. The prognosis is guarded to poor, with reported mortality rates ranging from 20% to 50% in dogs and cats, depending on the underlying cause, duration of peritonitis, and promptness of surgical intervention.

The etiologies of gastric perforation are diverse and can be categorized as traumatic, ulcerative, neoplastic, iatrogenic, or foreign body-related. Traumatic causes include penetrating abdominal wounds (e.g., bite wounds, gunshot injuries, impalement) and blunt trauma (e.g., vehicular trauma) that may cause gastric rupture due to sudden increases in intragastric pressure. Gastric ulceration is a common cause, often secondary to the use of non-steroidal anti-inflammatory drugs (NSAIDs), corticosteroids, or other ulcerogenic drugs, as well as conditions such as gastrinoma (Zollinger-Ellison syndrome), hepatic disease, renal failure, hypoadrenocorticism, mast cell tumors (histamine release), and inflammatory bowel disease. Gastric dilatation-volvulus (GDV) can lead to gastric necrosis and perforation, particularly if decompression is delayed. Foreign bodies, such as bones, sticks, or sharp objects, can cause pressure necrosis or direct penetration of the gastric wall. Iatrogenic perforation may occur during endoscopic procedures (e.g., biopsy, foreign body retrieval) or during surgery. Neoplastic conditions, including gastric adenocarcinoma, leiomyosarcoma, lymphoma, and gastrointestinal stromal tumors (GISTs), can ulcerate and perforate. Additionally, severe gastritis, parasitic infections (e.g., Physaloptera), and ingestion of corrosive substances can weaken the gastric wall. In cats, gastric perforation is less common but may be associated with linear foreign bodies, ulcers, or neoplasia.

Gastric perforation is an uncommon but serious condition in small animal practice. It occurs in both dogs and cats, with dogs being more frequently affected. There is no strong breed predilection, but breeds predisposed to GDV (e.g., Great Danes, German Shepherds, Standard Poodles) may be at higher risk for perforation secondary to GDV. Gastric ulceration and subsequent perforation are more common in dogs receiving NSAIDs, particularly older dogs with osteoarthritis. A retrospective study reported a median age of 8 years for dogs with gastric perforation, with no sex predilection. Cats are less commonly affected, but perforation may occur secondary to gastric lymphoma or inflammatory bowel disease. The incidence of gastric perforation is low, but it represents a significant cause of acute abdomen and peritonitis. Mortality rates are high, ranging from 20% to 50% in dogs, and are influenced by the presence of septic peritonitis, time to surgery, and underlying etiology.

The pathophysiology of gastric perforation involves a cascade of events leading to chemical and bacterial peritonitis. The stomach normally contains hydrochloric acid, pepsin, and a diverse microbiome. When a full-thickness defect occurs, gastric contents spill into the peritoneal cavity, causing immediate chemical irritation and inflammation. The acidic pH and digestive enzymes damage the peritoneal mesothelium, leading to increased vascular permeability, vasodilation, and exudation of protein-rich fluid. This is followed by bacterial contamination, with both aerobic and anaerobic organisms (e.g., Escherichia coli, Enterococcus spp., Clostridium spp., Bacteroides spp.) proliferating rapidly. The inflammatory response triggers the release of pro-inflammatory cytokines (TNF-α, IL-1, IL-6), leading to systemic inflammatory response syndrome (SIRS). If uncontrolled, this progresses to septic shock, characterized by hypotension, tissue hypoperfusion, lactic acidosis, and multi-organ dysfunction. The peritoneal cavity responds by forming fibrinous adhesions and attempting to wall off the contamination, but this is often insufficient. The presence of free gas and fluid in the abdomen further compromises organ function. The severity of peritonitis depends on the size and location of the perforation, the duration of contamination, and the host's immune response. Early surgical intervention is crucial to halt the progression.

Several factors predispose animals to gastric perforation. Intrinsic factors include age (older animals may have decreased mucosal protection), breed (e.g., deep-chested breeds for GDV), and concurrent diseases such as renal failure, hepatic disease, hypoadrenocorticism, and inflammatory bowel disease, which can compromise gastric mucosal integrity. Genetic factors may play a role in gastric neoplasia. Extrinsic factors include the use of ulcerogenic drugs (NSAIDs, corticosteroids), dietary indiscretion (foreign bodies, bones), stress (e.g., hospitalization, trauma), and previous gastric surgery. In cats, hyperthyroidism and chronic kidney disease may increase the risk of gastric ulceration. Additionally, any condition that increases intragastric pressure (e.g., gastric outflow obstruction, GDV) can predispose to perforation. Iatrogenic factors include endoscopic procedures and surgical manipulation.

Clinical signs of gastric perforation are often acute and severe, reflecting the onset of peritonitis. Animals typically present with a history of vomiting (often hematemesis), anorexia, lethargy, and abdominal pain. Physical examination reveals signs of shock, including tachycardia, weak pulses, pale mucous membranes, prolonged capillary refill time, and hypothermia or hyperthermia. Abdominal palpation may elicit pain, and a fluid wave or distension may be present. In cases of septic peritonitis, the animal may exhibit a 'praying' posture (cranial abdomen down) due to pain. As peritonitis progresses, signs of systemic inflammatory response syndrome (SIRS) may develop, including tachypnea, pyrexia or hypothermia, and altered mentation. In some cases, subcutaneous emphysema may be palpable if the perforation is associated with trauma. The severity of clinical signs correlates with the duration and extent of contamination. Early recognition is critical, as delayed treatment leads to rapid deterioration.

Differential diagnoses for gastric perforation include other causes of acute abdomen and peritonitis. These include: (1) Acute pancreatitis - presents with vomiting, abdominal pain, and may have elevated lipase and amylase; imaging may show pancreatic enlargement and peripancreatic fat stranding. (2) Intestinal foreign body with perforation - similar clinical signs, but imaging may reveal a foreign body and intestinal obstruction. (3) Septic peritonitis from other sources (e.g., intestinal dehiscence, biliary rupture, prostatic abscess) - requires exploratory surgery to identify the source. (4) Gastric dilatation-volvulus (GDV) - presents with abdominal distension, non-productive retching, and characteristic radiographic findings; perforation may be a complication. (5) Neoplastic gastric masses (e.g., adenocarcinoma, leiomyosarcoma) - may cause chronic vomiting and weight loss, and can perforate; imaging and biopsy are needed. (6) Severe gastroenteritis - may cause vomiting and abdominal pain but lacks peritoneal signs; imaging and laboratory tests help differentiate. (7) Uroperitoneum (ruptured bladder) - presents with azotemia, hyperkalemia, and abdominal effusion; abdominocentesis fluid has high creatinine and potassium. (8) Hepatic abscess or rupture - may cause peritonitis; imaging and liver enzymes are helpful. (9) Splenic torsion or infarction - can cause acute abdominal pain and shock; imaging and hematology may reveal characteristic findings. (10) Mesenteric volvulus - rare but causes rapid onset of shock and abdominal pain; imaging may show gas-filled loops. Definitive diagnosis often requires exploratory laparotomy.

The diagnostic algorithm for gastric perforation begins with a thorough history and physical examination. In any animal with acute abdomen and signs of shock, immediate stabilization is initiated (IV fluids, oxygen, analgesia). Baseline blood work (CBC, biochemistry, electrolytes, lactate) and blood gas analysis are performed. Abdominal radiographs (three-view: right lateral, left lateral, ventrodorsal) are obtained to assess for free gas (pneumoperitoneum), which is highly suggestive of gastrointestinal perforation. If radiographs are inconclusive, abdominal ultrasound is performed to detect free fluid, gastric wall thickening, or masses. Abdominocentesis or diagnostic peritoneal lavage is performed to obtain fluid for cytology and culture; the presence of intracellular bacteria, degenerate neutrophils, and plant fibers is consistent with septic peritonitis. If the patient is stable, advanced imaging such as CT may be used to further characterize the lesion, but in unstable patients, immediate exploratory laparotomy is indicated. Intraoperatively, the entire gastrointestinal tract is examined, and the perforation is identified. Biopsies are taken for histopathology if neoplasia is suspected. The diagnostic algorithm emphasizes rapid decision-making to minimize time to surgery.

Laboratory findings in gastric perforation reflect the systemic inflammatory response and peritonitis. Hematology may show leukocytosis with a left shift, or leukopenia in severe cases, indicating a poor prognosis. Toxic neutrophils may be seen. Packed cell volume (PCV) may be elevated due to dehydration or decreased due to blood loss. Serum biochemistry may reveal azotemia (pre-renal or renal), hyperglycemia or hypoglycemia, electrolyte imbalances (e.g., hypokalemia, hyponatremia), and elevated liver enzymes. Blood lactate is often elevated (>2.5 mmol/L) due to tissue hypoperfusion. Blood gas analysis may show metabolic acidosis with respiratory compensation. In cases of septic peritonitis, peritoneal fluid analysis is crucial: the fluid is typically turbid, with a nucleated cell count >5,000 cells/µL, predominantly degenerate neutrophils, and intracellular bacteria. Glucose concentration in the fluid is often <50 mg/dL, and lactate is higher than blood lactate. Cytology may also reveal plant fibers or foreign material. Culture and sensitivity of the fluid should be obtained, but antimicrobial therapy is initiated empirically. Coagulation parameters (PT, aPTT, platelet count) may be abnormal in cases of disseminated intravascular coagulation (DIC). Inflammatory biomarkers such as C-reactive protein (CRP) and serum amyloid A (SAA) may be elevated but are non-specific.

Imaging plays a critical role in the diagnosis of gastric perforation. Abdominal radiography is the first-line imaging modality. The most significant finding is pneumoperitoneum, which appears as free gas within the peritoneal cavity, often best visualized on a left lateral view (gas accumulates over the liver) or a dorsoventral view (gas under the diaphragm). However, pneumoperitoneum can also occur after recent surgery or penetrating trauma. Other radiographic signs include loss of serosal detail due to peritoneal effusion, gastric distension, or the presence of a radiopaque foreign body. In cases of GDV, the stomach may be distended and displaced. Abdominal ultrasonography is more sensitive for detecting small amounts of free gas and fluid. It can also assess gastric wall thickness, identify masses or ulcers, and guide abdominocentesis. Ultrasonographic signs of peritonitis include echogenic free fluid, hyperechoic mesentery, and gas artifacts. Computed tomography (CT) is increasingly used in stable patients and provides excellent detail of the gastrointestinal tract, free gas, and fluid. CT can help identify the exact location of perforation and underlying causes. However, in unstable patients, imaging should not delay surgery. Intraoperative imaging is not typically used, but fluoroscopy may be employed for contrast studies if a leak is suspected postoperatively.

Cytology of peritoneal fluid is essential for diagnosing septic peritonitis. The fluid is typically turbid and may have a foul odor. Cytological examination reveals a high nucleated cell count (often >10,000 cells/µL) with a predominance of degenerate neutrophils. Intracellular bacteria are a hallmark of septic peritonitis and confirm the diagnosis. Plant fibers or foreign material may also be seen. Histopathology of the gastric wall at the site of perforation is important to determine the underlying etiology. In cases of gastric ulceration, histopathology may show mucosal necrosis, inflammation, and fibrosis. If neoplasia is present, the tumor type and grade are determined. For example, gastric adenocarcinoma may show malignant epithelial cells with glandular differentiation, while leiomyosarcoma shows spindle cells with smooth muscle markers. Biopsies of the perforation margin should be taken during surgery, and if the entire lesion is resected, margins are evaluated. Special stains (e.g., Giemsa for Helicobacter-like organisms) may be performed if infectious causes are suspected. Histopathology is also useful to assess the degree of inflammation and necrosis, which can guide prognosis.

Treatment of gastric perforation is primarily surgical and must be initiated as soon as the patient is stabilized. Preoperative stabilization includes aggressive intravenous fluid therapy with isotonic crystalloids (e.g., Lactated Ringer's solution) at shock doses (e.g., 20-30 mL/kg bolus in dogs, 10-20 mL/kg in cats, repeated as needed), colloids (e.g., hetastarch) if hypoproteinemia, and vasopressors (e.g., norepinephrine) if hypotension persists. Broad-spectrum antimicrobial therapy is started immediately, typically with a combination of a beta-lactam (e.g., ampicillin 22 mg/kg IV q8h), an aminoglycoside (e.g., gentamicin 6-8 mg/kg IV q24h, but caution with renal function) or a fluoroquinolone (e.g., enrofloxacin 5-10 mg/kg IV q24h), and metronidazole (10-15 mg/kg IV q12h). Analgesia is provided with opioids (e.g., hydromorphone 0.05-0.1 mg/kg IV q4-6h, or fentanyl CRI at 2-5 µg/kg/h). Surgical exploration is performed via a midline celiotomy. The entire gastrointestinal tract is examined. The perforation is identified, and the surrounding necrotic tissue is debrided. If the perforation is small and healthy tissue is present, primary closure is performed using a simple interrupted or continuous pattern with absorbable monofilament suture (e.g., polydioxanone, 3-0 or 2-0) in a single or double layer (e.g., appositional plus inverting). If the perforation is large or the tissue is compromised, a partial gastrectomy (wedge resection) or gastrectomy may be required. In cases of GDV, the stomach is derotated and devitalized tissue is resected. After closure, the abdomen is copiously lavaged with warm sterile saline (0.9% NaCl) or lactated Ringer's solution, using 200-500 mL/kg, and suctioned. A closed-suction drain may be placed if there is severe peritonitis, but its use is controversial. Postoperative care includes continued fluid therapy, antimicrobials, analgesia, and nutritional support (e.g., early enteral feeding via esophagostomy or gastrostomy tube if needed). The patient is monitored closely for complications such as dehiscence, ileus, and sepsis.

The prognosis for gastric perforation is guarded to poor, with reported mortality rates ranging from 20% to 50% in dogs and cats. Factors associated with a worse prognosis include: presence of septic peritonitis, delay in surgical intervention (>24 hours), hypotension at presentation, elevated lactate (>2.5 mmol/L), leukopenia, and the need for extensive gastric resection. The underlying etiology also influences prognosis; perforation due to foreign body or trauma may have a better outcome than perforation secondary to neoplasia or severe ulcerative disease. Postoperative complications such as peritonitis, dehiscence, and sepsis significantly increase mortality. However, with prompt surgical intervention and aggressive perioperative management, many animals can survive. Long-term prognosis is good if the underlying cause is resolved and no complications occur. For animals with gastric neoplasia, the prognosis is poor due to the high likelihood of metastasis.

Postoperative follow-up is crucial for monitoring recovery and detecting complications. Immediately after surgery, the patient is hospitalized in an intensive care unit for at least 24-72 hours. Vital parameters (heart rate, respiratory rate, blood pressure, temperature) are monitored frequently. Serial blood work (CBC, biochemistry, lactate, blood gas) is performed daily to assess metabolic status and organ function. Abdominal ultrasound may be used to monitor for free fluid or abscess formation. The surgical incision is checked daily for signs of infection or dehiscence. Suture removal is typically performed 10-14 days postoperatively. Activity is restricted for 2-4 weeks to allow healing. Nutritional support is gradually reintroduced, starting with small, frequent meals of a bland diet. If a feeding tube was placed, it is maintained until the animal is eating adequately. Recheck examinations are scheduled at 1, 2, 4, and 8 weeks postoperatively. At each visit, a physical examination and possibly blood work are performed. Long-term follow-up is recommended for animals with underlying conditions such as inflammatory bowel disease or neoplasia. Owners are educated on the signs of recurrence (vomiting, abdominal pain, lethargy) and the importance of avoiding ulcerogenic drugs.

Clinical pearls: (1) Always consider gastric perforation in any animal with acute abdomen and free gas on radiographs; do not delay surgery for extensive diagnostics. (2) During surgery, perform a thorough exploration of the entire gastrointestinal tract, as multiple perforations may exist. (3) Use omental patching to reinforce the closure of a gastric perforation, as it provides a blood supply and seals the defect. (4) Obtain peritoneal fluid for culture and sensitivity before starting antibiotics, but do not delay antibiotics. (5) In cases of GDV, inspect the stomach carefully for necrotic areas, especially along the greater curvature, and resect devitalized tissue. (6) Postoperative ileus is common; consider prokinetic agents (e.g., metoclopramide) if needed. Pitfalls: (1) Underestimating the severity of peritonitis and failing to provide aggressive fluid resuscitation. (2) Inadequate debridement of necrotic tissue, leading to dehiscence. (3) Using non-absorbable suture or inappropriate suture pattern, increasing the risk of leakage. (4) Not placing a feeding tube in anorexic patients, leading to malnutrition and delayed healing. (5) Discharging the patient too early, before ensuring stable vital signs and oral intake.

Perioperative antimicrobial protocols: For septic peritonitis, a combination of a beta-lactam (e.g., ampicillin 22 mg/kg IV q8h), an aminoglycoside (e.g., gentamicin 6-8 mg/kg IV q24h, with monitoring of renal function) or a fluoroquinolone (e.g., enrofloxacin 5-10 mg/kg IV q24h), and metronidazole (10-15 mg/kg IV q12h) is recommended. Alternatively, a third-generation cephalosporin (e.g., cefotaxime 25-50 mg/kg IV q8h) or a carbapenem (e.g., meropenem 8.5 mg/kg IV q12h) may be used. Antimicrobial therapy should be adjusted based on culture and sensitivity results and continued for 7-14 days postoperatively. Analgesia: Opioids are the mainstay for postoperative pain. Options include hydromorphone (0.05-0.1 mg/kg IV q4-6h), morphine (0.5-1 mg/kg IM/SC q4-6h), or fentanyl CRI (2-5 µg/kg/h). A lidocaine CRI (25-50 µg/kg/min) may be added for additional analgesia and to reduce anesthetic requirements. NSAIDs are generally avoided in the perioperative period due to the risk of gastric ulceration and renal impairment, but if used, they should be started only after the animal is stable and eating. Gastroprotectants: Proton pump inhibitors (e.g., omeprazole 0.7-1 mg/kg PO q12h) or H2 antagonists (e.g., famotidine 0.5-1 mg/kg IV/PO q12h) are used to reduce gastric acid secretion and prevent further ulceration. Sucralfate (0.5-1 g PO q8h) may be used as a cytoprotectant. Antiemetics: Maropitant (1-2 mg/kg SC q24h) or metoclopramide (1-2 mg/kg/day CRI) may be used to control vomiting. Nutritional support: If the animal is anorexic for >3 days, a feeding tube (esophagostomy or gastrostomy) should be placed, and a balanced liquid diet (e.g., Hill's a/d) is administered. Prokinetics: Metoclopramide (1-2 mg/kg/day CRI) or cisapride (0.5 mg/kg PO q8h) may be used to manage ileus. All dosages are based on Plumb's Veterinary Drug Handbook.

Evidence-based literature on gastric perforation in small animals is limited to retrospective studies and case series. A landmark retrospective study by Lanz et al. (2001) evaluated 50 dogs with gastric perforation and found a mortality rate of 40%. Factors associated with death included the presence of septic peritonitis, elevated lactate, and delayed surgery. Another study by Gorman et al. (2009) reported a mortality rate of 30% in dogs with gastric perforation secondary to ulceration, with NSAID use being a common cause. In cats, a study by Kuan et al. (2010) reported a mortality rate of 50%, with gastric lymphoma being a common underlying cause. Consensus guidelines from the American College of Veterinary Surgeons (ACVS) and the European College of Veterinary Surgeons (ECVS) recommend early surgical intervention, aggressive fluid therapy, and broad-spectrum antimicrobials for septic peritonitis. There is ongoing debate regarding the use of closed-suction drains versus open peritoneal drainage; a prospective study by Mueller et al. (2001) found no significant difference in outcome. The use of omental patching has been shown to reduce the risk of dehiscence in experimental studies. Overall, the literature emphasizes the importance of prompt diagnosis and surgical treatment to improve survival.